Paydirt
JS
Insider

Jeffrey T L Smith

EVP & Chief Medical Officer

Jeffrey T L Smith (EVP & Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in ZYME. The largest single filing was $265K of ZYME (10,538 sh × $25.10, as filed), executed Jan 5.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$476K
shares × price, as filed
Last traded
Jan 12
Filed Jan 12
Open performance
Volume by month
$476K$238K$0Oct 2024Apr 2025Oct 2025Apr 2026Jan 2025 · sells $166KJan 2026 · sells $476K
Buys $0 Sells $641K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 2 filings

Sector per market data · by filing · past 12 months

Most traded names
ZYME ZYME ZYME · 0 buys · 3 sells 3 filings
Recent filings
ZYMESALE Zymeworks Inc. View filing → $211K
9,310 sh × $22.67
Exec Jan 12
Filed Jan 12 · 5:30 PM ET
ZYMESALE Zymeworks Inc. View filing → $265K
10,538 sh × $25.10
Exec Jan 5
Filed Jan 5 · 5:30 PM ET
ZYMESALE Zymeworks Inc. View filing → $166K
11,110 sh × $14.92
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET